Product Information
PYRIDOSTIGMINE 60 MG/5 ML SOLN is a generic product labeled by Novitium Pharma LLC, priced at $0.5648 per ML under NDC 70954014810. Its NADAC has been published 129 times since Apr 17, 2024.
FDA first approved this application on Mar 8, 2019. Its Orange Book therapeutic-equivalence code is AA.
Strength
60 mg/5mL
Manufacturer
Novitium Pharma LLCNDC
70954014810
Classification
Generic
Dosage Form
SOLUTION
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
PYRIDOSTIGMINE BROMIDEApproval Type
Generic (ANDA)
FDA Application
ANDA211694FDA Approved
3/8/2019
TE Code
AA
On Market Since
3/11/2019
Pharmacological Classes
Price Statistics
The NADAC for PYRIDOSTIGMINE 60 MG/5 ML SOLN has been published 129 times since Apr 17, 2024, and over the history we have for it it has declined 59.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.5648 per ML |
|---|---|
| All-time high | $1.4070 (May 15, 2024) |
| All-time low | $0.4572 (Jul 22, 2026) |
| 52-week high | $0.7605 |
| 52-week low | $0.4572 |
| Median price | $0.8421 |
| Average price | $0.7789 |
| Largest weekly change | -35.4% (May 22, 2024) |
| Weeks tracked | 129 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Pyridostigmine bromide oral market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Novitium Pharma LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Pyridostigmine bromide oral market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Cholinesterase Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of PYRIDOSTIGMINE 60 MG/5 ML SOLN?
The current National Average Drug Acquisition Cost (NADAC) for PYRIDOSTIGMINE 60 MG/5 ML SOLN, manufactured by Novitium Pharma LLC, is $0.5648 per ML (NDC 70954014810), effective Sep 30, 2026.
How has the price of PYRIDOSTIGMINE 60 MG/5 ML SOLN changed over time?
Over the history we have for it, the NADAC for PYRIDOSTIGMINE 60 MG/5 ML SOLN has declined 59.9%. It has been tracked across 129 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for PYRIDOSTIGMINE 60 MG/5 ML SOLN?
Since Apr 17, 2024, the NADAC for PYRIDOSTIGMINE 60 MG/5 ML SOLN has ranged from a low of $0.4572 (Jul 22, 2026) to a high of $1.4070 (May 15, 2024), with a median of $0.8421 per ML.
Are there cheaper alternatives to PYRIDOSTIGMINE 60 MG/5 ML SOLN?
No other NADAC-published product currently shares the active ingredient and strength of PYRIDOSTIGMINE 60 MG/5 ML SOLN in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures PYRIDOSTIGMINE 60 MG/5 ML SOLN?
PYRIDOSTIGMINE 60 MG/5 ML SOLN (NDC 70954014810) is labeled by Novitium Pharma LLC, and CMS classifies it as a generic product.